World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
146
Citations
113144
World Ranking
1315
National Ranking
757

Marc S. Sabatine publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Marc S. Sabatine sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 675 publications — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Marc S. Sabatine D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Marc S. Sabatine sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 146 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Marc S. Sabatine is affiliated with Brigham and Women's Hospital in the United States. Their research spans multiple areas within medicine, with a significant emphasis on cardiology and cardiovascular medicine, endocrinology, diabetes and metabolism, surgery, molecular biology, and economics and econometrics.

Sabatine's publication record includes extensive work in several topics, primarily:

  • Diabetes Treatment and Management
  • Lipoproteins and Cardiovascular Health
  • Cardiovascular Function and Risk Factors
  • Pancreatic Function and Diabetes
  • Metabolism, Diabetes, and Cancer
  • Heart Failure Treatment and Management
  • Antiplatelet Therapy and Cardiovascular Diseases

Their research output features frequent publication in key journals, highlighting their role in cardiology and metabolic fields. Notable venues include:

  • Circulation
  • Journal of the American College of Cardiology
  • JAMA Cardiology
  • European Heart Journal
  • JACC Heart Failure

Collaborations play a significant part in their work, with repetitive co-authorship alongside researchers such as:

  • Robert P. Giugliano
  • John J.V. McMurray
  • Anna Maria Langkilde
  • Pardeep S. Jhund
  • Scott D. Solomon

Selected recent papers authored or co-authored by Sabatine include the following:

  • "Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials," 2022, published in The Lancet
  • "Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes," 2020, published in JAMA
  • "Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus," 2020, published in Circulation
  • "Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease," 2022, published in New England Journal of Medicine
  • "Long-Term Evolocumab in Patients With Established Atherosclerotic Cardiovascular Disease," 2022, published in Circulation

Best Publications

  • 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

    François Mach;Colin Baigent;Alberico L Catapano;Konstantinos C Koskinas

  • Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

    Marc S. Sabatine;Robert P. Giugliano;Anthony C. Keech;Narimon Honarpour

  • Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    John J.V. McMurray;Scott D. Solomon;Silvio E. Inzucchi;Lars Køber

  • 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

    Ezra A. Amsterdam;Nanette K. Wenger;Ralph G. Brindis;Donald E. Casey

  • Cytochrome P-450 Polymorphisms and Response to Clopidogrel

    Jessica L. Mega;Sandra L. Close;Stephen D. Wiviott;Lei Shen

  • Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation

    Marc S. Sabatine;Christopher P. Cannon;C. Michael Gibson;Jose L. López-Sendón

  • SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

    Thomas A Zelniker;Stephen D Wiviott;Itamar Raz;Kyungah Im

  • Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

    Marc P. Bonaca;Deepak L. Bhatt;Marc Cohen;Philippe Gabriel Steg

  • The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes.

    James A. de Lemos;David A. Morrow;Jane H. Bentley;Torbjørn Omland

  • 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

    Glenn N. Levine;Eric R. Bates;John A. Bittl;Ralph G. Brindis

  • Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy A Meta-analysis

    David Preiss;Sreenivasa Rao Kondapally Seshasai;Paul Welsh;Sabina A. Murphy

  • 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes: Executive Summary

    Ezra A. Amsterdam;Nanette K. Wenger;Ralph G. Brindis;Donald E. Casey

  • Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.

    Jessica L. Mega;Tabassome Simon;Jean Philippe Collet;Jeffrey L. Anderson

  • Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis

    Michael G. Silverman;Brian A. Ference;Kyungah Im;Stephen D. Wiviott

  • 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

    Ezra A. Amsterdam;Nanette K. Wenger;Ralph G. Brindis;Donald E. Casey

  • Myocardial infarction accelerates atherosclerosis

    Partha Dutta;Gabriel Courties;Ying Wei;Florian Leuschner;Florian Leuschner

  • A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery Disease

    Torbjørn Omland;James A de Lemos;Marc S. Sabatine;Costas A. Christophi

  • Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events

    M.S. Sabatine;R.P. Giugliano;S.D. Wiviott

  • Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy

    David Preiss;Sreenivasa Rao Kondapally;Paul Welsh;Sabina A. Murphy

  • Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation

    Marc S. Sabatine;Christopher P. Cannon;C. Michael Gibsonn;Jose L. Lopez-Sendon

Frequent Co-Authors

David A. Morrow
David A. Morrow Brigham and Women's Hospital
Eugene Braunwald
Eugene Braunwald Harvard Medical School
Sabina A. Murphy
Sabina A. Murphy Brigham and Women's Hospital
Stephen D. Wiviott
Stephen D. Wiviott Brigham and Women's Hospital
Christopher P. Cannon
Christopher P. Cannon Brigham and Women's Hospital
Robert P. Giugliano
Robert P. Giugliano Brigham and Women's Hospital
Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Elliott M. Antman
Elliott M. Antman Brigham and Women's Hospital
C. Michael Gibson
C. Michael Gibson Beth Israel Deaconess Medical Center
Anthony C. Keech
Anthony C. Keech University of Sydney

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees can open new routes for those interested in the healthcare field, especially for students considering Medicine in the USA. Many choose alternative pathways like nursing or advanced practice roles as a stepping stone or career option. Finding the cheapest dnp online program can be an affordable way to achieve a doctoral degree in nursing and increase your clinical or academic impact.

For registered nurses, upgrading qualifications is possible through flexible options such as the rn to bsn online pathway. Those without a nursing background but ready to shift careers might explore direct entry msn programs online, designed for non-nurses who want to quickly enter the profession at a graduate level.

For applicants seeking accessible options, reviewing the easiest nursing programs to get into can smooth the process of school admission. With the rise of online learning, these pathways offer flexibility, cost savings, and opportunities to start or accelerate a healthcare career.

Best Scientists Citing Marc S. Sabatine

Trending Scientists

Recently Published Articles